Huddersfield
Colonics

A defect in the abdominal wall can create a risk of strangulation of the bowel.

A tear or crack in the anus, usually very painful when active. This can range from a small crack to an open fissure requiring surgery.

The supplied guidance lists colitis, ulcerative colitis, Crohn’s disease, diverticulosis and diverticulitis. Active, recent or unstable flare-ups carry risks of bleeding and tissue damage, and treatment may exacerbate symptoms.

The guidance says not to treat within three months of a flare-up, and to consider the longer-term history, including at least the previous year.

Important exception in the supplied guidance: a person in stable remission may be considered only after an individual assessment by a practitioner with the relevant knowledge and experience. Remission or the passage of three months does not automatically make treatment suitable. If there is doubt, treatment should not proceed. Discuss this with the clinic and your treating medical professional before booking.

An abscess may tunnel into the rectum, sometimes requiring surgery.

The supplied guidance excludes people taking warfarin or treatment-dose injectable anticoagulants, such as dalteparin or tinzaparin.

It distinguishes some low-dose preventative anticoagulant use. Any possible exception must be reviewed individually with the clinic and the prescribing medical professional. Do not stop or change medication to qualify for treatment.

The supplied guidance advises against treatment because of sudden changes in heart rate.

This may occur with spinal injuries at or above T6. The supplied guidance identifies a danger of body spasms, particularly in relation to insertion of the speculum.

Examples include obstruction caused by adhesions, volvulus or a tumour. This requires medical attention, not colonic treatment.

The supplied guidance distinguishes bowel obstruction from faecal impaction associated with chronic constipation. Do not use this list to diagnose the difference yourself.

Weakened tissues may no longer support the organs properly. Treatment could make the condition worse.

The supplied guidance identifies risks of perforation and bleeding where the bowel is diseased or vulnerable to damage.

Do not have treatment while receiving chemotherapy. The supplied guidance identifies infection risks associated with a low immune response or neutropenia.

It refers to a minimum three-month interval and blood levels returning to normal. This is not automatic clearance: discuss timing, recovery and suitability with the oncology team and the clinic.

The supplied guidance identifies a risk of hypoglycaemia during treatment. Discuss diabetes and its management with the clinic before booking.

The supplied guidance says not to treat unless the person holds, or would qualify for, a driving licence. This fitness-to-drive criterion is part of the supplied document, not confirmation that treatment is safe. Individual medical and practitioner assessment is required.

The supplied guidance advises against treatment where heart failure requires medical care, ongoing monitoring and medication. Its document cites cardiac consultant advice from April 2021.

High blood pressure that is uncontrolled or known to be outside the normal range is excluded in the supplied guidance because of the risk of stroke or heart attack.

Treatment may worsen symptoms and cause pain or bleeding.

The bowel telescopes into itself. The supplied guidance advises against treatment.

Any condition that reduces liver function needs individual assessment, including consideration of ongoing medical care. Contact the clinic and your treating medical professional before booking.

A low neutrophil count can severely reduce the body’s ability to fight infection. The supplied guidance advises against treatment because of the infection risk.

The supplied guidance lists pregnancy as a contraindication and identifies a risk of miscarriage. Do not book treatment during pregnancy.

The supplied guidance advises against treatment because structurally weak, unsupported tissue may be further damaged and the condition could become a medical emergency.

The supplied guidance excludes treatment while still under medical care and states a two-year interval after abdominal radiotherapy. It identifies tissue damage and perforation risks.

The passage of two years does not itself confirm suitability. Discuss this with the treating medical team and the clinic before booking.

Rectal bleeding should be discussed with a GP and investigated as appropriate before treatment.

The supplied document mentions an exception for a small speck of blood on tissue after straining to pass a large stool. Do not assume bleeding is harmless or use that exception to clear yourself for treatment; seek medical advice if it is unexplained, recurrent or concerning.

The supplied guidance specifies at least 50% kidney function with two kidneys, or 100% with one kidney, with no fluid restriction.

These are the supplied document’s thresholds, not a self-assessment or permission to proceed. Reduced kidney function, renal insufficiency or a medically supervised reduction in fluid intake requires discussion with the treating medical professional and the clinic. Do not change a prescribed fluid restriction.